Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Toshika, Okumiya"'
Autor:
Ohki Hayashi, Seishi Nakamura, Tetsuro Sugiura, Shun Hasegawa, Yoshiaki Tsuka, Nobuyuki Takahashi, Sanae Kikuchi, Koichiro Matsumura, Toshika Okumiya, Masato Baden, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background The improvement of anaemia over time by erythropoiesis stimulating agent (ESA) is associated with better survival in haemodialysis patients. We previously reported that erythrocyte creatine content, a marker of erythropoietic capa
Externí odkaz:
https://doaj.org/article/6feceb4db1534476b48b69f9c048d595
Autor:
Shun Hasegawa, Seishi Nakamura, Tetsuro Sugiura, Yoshiaki Tsuka, Nobuyuki Takahashi, Koichiro Matsumura, Toshika Okumiya, Masato Baden, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background One of the main causes of anaemia in patients with end-stage renal disease is relative deficiency in erythropoietin production. Eythropoiesis stimulating agent (ESA), a potent haematopoietic growth factor, is used to treat anaemia
Externí odkaz:
https://doaj.org/article/cc95294efc7b419c9aec6a270dde364a
Autor:
Masashi Kameyama, Toshika Okumiya, Shinji Tokuhiro, Yoshihisa Matsumura, Hirotaka Matsui, Yasuhiro Ono, Tsuyoshi Iwasaka, Kazuyuki Hiratani, Masafumi Koga
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract In a previous study, a method of obtaining mean erythrocyte age ( $$M_{RBC}$$ M RBC ) from HbA1c and average plasma glucose (AG) was proposed. However, the true value of the hemoglobin glycation constant ( $$k_g$$ k g dL/mg/day), required fo
Externí odkaz:
https://doaj.org/article/70bf3df3f6d749e0b0900dcb123fee2e
Autor:
Koichiro Matsumura, Toshika Okumiya, Tetsuro Sugiura, Nobuyuki Takahashi, Yoshihiro Yamamoto, Sanae Kikuchi, Kenichi Fujii, Munemitsu Otagaki, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background The causes of anaemia in patients with end-stage renal disease include a relative deficiency in erythropoietin production and complex clinical conditions. We aimed to investigate the underlying mechanisms of anaemia in patients wi
Externí odkaz:
https://doaj.org/article/85100b00e73d4be48acef866ef83f9d6
Autor:
Haruki Odaka, Tadahiro Numakawa, Minami Soga, Jun Kido, Shiro Matsumoto, Ryutaro Kajihara, Toshika Okumiya, Naoki Tani, Yuki Tanoue, Takaichi Fukuda, Hirokazu Furuya, Takafumi Inoue, Takumi Era
Publikováno v:
Neurobiology of Disease, Vol 152, Iss , Pp 105279- (2021)
Sialidosis is a neuropathic lysosomal storage disease caused by a deficiency in the NEU1 gene-encoding lysosomal neuraminidase and characterized by abnormal accumulation of undigested sialyl-oligoconjugates in systemic organs including brain. Althoug
Externí odkaz:
https://doaj.org/article/d2ee334841064119b1d66c5b560c755b
Autor:
Hiroko Ijima, Kazuyuki Hiratani, Hideaki Jinnnouchi, Yasuhiro Ono, Masashi Kameyama, Toshika Okumiya, Masafumi Koga
Publikováno v:
Clinical Biochemistry. 107:50-54
Whereas HbA1c values are low relative to glycemia in patients with hemolytic anemia, including compensatory anemia, low HbA1c levels along with negative results for conventional hemolysis indicators have been reported in patients with latent hemolysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d888c33aac9810bb60733cf4da5f03c
https://doi.org/10.1016/j.clinbiochem.2022.05.007
https://doi.org/10.1016/j.clinbiochem.2022.05.007
Autor:
Ohki, Hayashi, Seishi, Nakamura, Tetsuro, Sugiura, Shun, Hasegawa, Yoshiaki, Tsuka, Nobuyuki, Takahashi, Sanae, Kikuchi, Koichiro, Matsumura, Toshika, Okumiya, Masato, Baden, Ichiro, Shiojima
Background The improvement of anaemia over time by erythropoiesis stimulating agent (ESA) is associated with better survival in haemodialysis patients. We previously reported that erythrocyte creatine content, a marker of erythropoietic capacity, was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1249ca18382061da45eec4342951ade
https://doi.org/10.21203/rs.3.rs-2183749/v1
https://doi.org/10.21203/rs.3.rs-2183749/v1
Autor:
Toshika Okumiya, Haruki Odaka, Hirokazu Furuya, Tadahiro Numakawa, Noemi Fusaki, Yuji Yaginuma, Seiji Inui, Ryutaro Kajihara, Takumi Era
Publikováno v:
Stem Cell Reports
Summary GM1 gangliosidosis is a lysosomal storage disease caused by loss of lysosomal β-galactosidase activity and characterized by progressive neurodegeneration due to massive accumulation of GM1 ganglioside in the brain. Here, we generated induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec6f7433d1d91f8c7223d982e462f4b
http://europepmc.org/articles/PMC7220856
http://europepmc.org/articles/PMC7220856
Autor:
Nao Wakuta, Tadashi Matsubayashi, Keiko Oba, Hiromi Nakashima, Ken Suzuki, Toshika Okumiya, Midori Ishibashi, Masafumi Koga
Publikováno v:
Annals of Clinical & Laboratory Science; Jan/Feb2023, Vol. 53 Issue 1, p134-139, 6p
Autor:
Koichiro Matsumura, Tetsuro Sugiura, Toshika Okumiya, Seishi Nakamura, Yoshiaki Tsuka, Shun Hasegawa, Nobuyuki Takahashi, Masato Baden, Ichiro Shiojima
Background: One of the main causes of anaemia in patients with end-stage renal disease is relative deficiency in erythropoietin production. Recombinant human erythropoietin (rHuEpo), a potent haematopoietic growth factor, is used to treat anaemia in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::039b1fb03e9f43aedd9312d871013817
https://doi.org/10.21203/rs.3.rs-792979/v1
https://doi.org/10.21203/rs.3.rs-792979/v1